Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $59.20 Average Target Price from Brokerages
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has earned a consensus recommendation of “Buy” from the eight analysts that are covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has earned a consensus recommendation of “Buy” from the eight analysts that are covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among […]
